Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 3
  • Print publication year: 2004
  • Online publication date: December 2009

5 - Quality of life in breast cancer: what have we learned and where do we go from here?

Summary

Introduction

Breast cancer is the most common cancer in North American women, accounting for about a third of all incident cancers. In 2004 in the USA, there are projected to be 215 900 newly diagnosed cases of female breast cancer and 40 110 deaths. During the past 5 years, the mortality rate for breast cancer has declined significantly, most likely due to a combination of wider use of mammographic screening and the diffusion of adjuvant therapy for stage I and II disease. In spite of this improvement in mortality, the number of incident cases of breast cancer is projected to rise with the continued aging of the population, as breast cancer peaks in women in the 8th decade of life.– Unless major advances in the prevention of breast cancer occur, using chemoprevention and other risk reduction strategies, the absolute number of breast cancer patients and survivors will continue to increase as we move further into the 21st century.

The majority of women with breast cancer are diagnosed with early-stage localized disease. In fact, tumor size at diagnosis has continued to decrease, with very small invasive and non-invasive cancers being detected through mammographic screening. Some series estimate that about 20% of incident cases are now non-invasive (stage 0) ductal carcinoma in situ. However, in spite of these decreases in tumor size and invasiveness, almost all patients diagnosed with breast cancer receive localized breast surgery (breast-conserving surgery and radiation to the breast or a modified radical mastectomy, with or without reconstruction).

REFERENCES
Jemal, A., Tiwari, R. C., Murray, T.et al. (2004). Cancer statistics, 2004.CA: Cancer Journal for Clinicians 54:8–29
Howe, H. L., Wingo, P. A., Thun, M. J. et al. (2001). Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.Journal of the National Cancer Institute 93:824–42
Yancik, R., Ries, L. G., Yates, J. W. (1989). Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival.Cancer 63:976–81
Yancik, R. (1997). Epidemiology of cancer in the elderly. Current status and projections for the future.Rays 22:3–9
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K. et al. (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.Journal of the National Cancer Institute 90:1371–88
National Institutes of Health (1990). Early stage breast cancer.Consensus Statement 8:1–19
National Institutes of Health (2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1–3, 2000. Journal of the National Cancer Institute 93:979–89
Early Breast Cancer Trialists' Collaborative Group. (1998). Tamoxifen for early breast cancer: an overview of the randomised trials.Lancet 351:1451–67
Early Breast Cancer Trialists' Collaborative Group. (1998). Polychemotherapy for early breast cancer: an overview of the randomised trials.Lancet 352:930–42
Shapiro, C. L., Recht, A. (2001). Side effects of adjuvant treatment of breast cancer.New England Journal of Medicine 344:1997–2008
Priestman, T. J., Baum, M. (1976). Evaluation of quality of life in patients receiving treatment for advanced breast cancer.Lancet 1:899–900
Selby, P. J., Chapman, J. A., Etazadi-Amoli, J.et al. (1984). The development of a method for assessing the quality of life of cancer patients.British Journal of Cancer 50:13–22
Schag, C. C., Heinrich, R. L., Ganz, P. A. (1983). Cancer inventory of problem situations: an instrument for assessing cancer patients' rehabilitation needs.Journal of Psychosocial Oncology 1:11–24
Schipper, H., Clinch, J., McMurray, A.et al. (1984). Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.Journal of Clinical Oncology 2:472–83
Schag, C. A., Heinrich, R. L. (1990). Development of a comprehensive quality of life measurement tool: CARES.Oncology 4:135–8
Spiegel, D., Bloom, J. R., Yalom, I. (1981). Group support for patients with metastatic cancer. A randomized prospective outcome study.Archives of General Psychiatry 38:527–33
Ganz, P. A., Coscarelli, A., Fred, C.et al. (1996). Breast cancer survivors: psychosocial concerns and quality of life.Breast Cancer Research and Treatment 38:183–99
Meyerowitz, B. E. (1980). Psychosocial correlates of breast cancer and its treatments.Psychological Bulletin 87:108–31
McNair, P. M., Lorr, M., Droppelman, L. EDITS Manual for Profile of Mood States. (1981). San Diego: Educational and Industrial Testing Service
Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population.Applied Psychological Measurement 1:385–401
Coates, A., Gebski, V., Bishop, J. F.et al. (1987). Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.New England Journal of Medicine 317:1490–5
Aaronson, N. K., Ahmedzai, S., Bergman, B.et al., for the EORTC Study Group on Quality of Life. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.Journal of the National Cancer Institute 85:365–76
Cella, D. F., Tulsky, D. S., Gray, G.et al. (1993). The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.Journal of Clinical Oncology 11:570–9
Schag, C. A., Heinrich, R. L., Aadland, R. L.et al. (1990). Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations.Health Psychology 9:83–102
Ganz, P. A., Schag, C. A., Lee, J. J.et al. (1992). The CARES: a generic measure of health-related quality of life for patients with cancer.Quality of Life Research 1:19–29
Schag, C. A., Ganz, P. A., Heinrich, R. L. (1991). Cancer Rehabilitation Evaluation System — short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument.Cancer 68:1406–13
Levine, M. N., Guyatt, G. H., Gent, M.et al. (1988). Quality of life in stage II breast cancer: an instrument for clinical trials.Journal of Clinical Oncology 6:1798–1810
Sprangers, M. A., Groenvold, M., Arraras, J. I.et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.Journal of Clinical Oncology 14:2756–68
Brady, M. J., Cella, D. F., Mo, F.et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.Journal of Clinical Oncology 15:974–86
National Institutes of Health (1985). Consensus conference. Adjuvant chemotherapy for breast cancer.Journal of the American Medical Association 254:3461–3
Feeny, this volume, Chapter 4
Erickson, this volume, Chapter 3
Ganz, P. A., Schag, A. C., Lee, J. J.et al. (1992). Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery?Cancer 69:1729–38
Ganz, P. A., Schag, C. A., Cheng, H. L. (1990). Assessing the quality of life — a study in newly-diagnosed breast cancer patients.Journal of Clinical Epidemiology 43:75–86
Schag, C. A., Ganz, P. A., Polinsky, M. L.et al. (1993). Characteristics of women at risk for psychosocial distress in the year after breast cancer.Journal of Clinical Oncology 11:783–93
Lindley, C., Vasa, S., Sawyer, W. T.et al. (1998). Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.Journal of Clinical Oncology 16:1380–7
Ingham, J., Seidman, A., Yao, T. J.et al. (1996). An exploratory study of frequent pain measurement in a cancer clinical trial.Quality of Life Research 5:503–7
Seidman, A. D., Portenoy, R., Yao, T. J.et al. (1995). Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor.Journal of the National Cancer Institute 87:1316–22
Chu, L., Sutton, L. M., Peterson, B. L.et al. (1996). Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.Journal of Infusional Chemotherapy 6:211–6
Edmonds, C. V., Lockwood, G. A., Cunningham, A. J. (1999). Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients.Psycho-Oncology. 8:74–91
Goss, P. E. (1998). Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor.Breast Cancer Research and Treatment 49 (Suppl. 1):S59–65
Kornblith, A. B., Hollis, D. R., Zuckerman, E.et al. (1993). Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.Journal of Clinical Oncology 11:2081–9
Riley, B. B., Perna, R., Tate, D. G.et al. (1998). Types of spiritual well-being among persons with chronic illness: their relation to various forms of quality of life.Archives of Physical Medicine and Rehabilitation 79:258–64
Tate, D. G., Riley, B. B., Perna, R.et al. (1997). Quality of life issues among women with physical disabilities or breast cancer.Archives of Physical Medicine and Rehabilitation 78:S18–25
Winer, E. P., Lindley, C., Hardee, M.et al. (1999). Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.Psycho-Oncology 8:167–76
De Haes, J. C. J. M., Pruyn, J. F. A., van Knippenberg, F. C. E., klachtenlijst voor kankerpatienten, eerste ervaringen. (1983). Netherlands Tijdschrift voor de Psychologie en Haar Grensgebieden 38:403
Watson, M., Law, M., Maguire, G. P.et al. (1992). Further development of a quality of life measure for cancer patients: The Rotterdam Symptom Checklist (Revised).Psycho-Oncology 1:35–44
Bosnjak, S., Radulovic, S., Neskovic-Konstantinovic, Z.et al. (2000). Patient statement of satisfaction with antiemetic treatment is related to quality of life.American Journal of Clinical Oncology 23:575–8
Hall, A., A'Hern, R., Fallowfield, L. (1999). Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?European Journal of Cancer 35:79–85
Jansen, S. J., Stiggelbout, A. M., Nooij, M. A.et al. (2000). Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy.Quality of Life Research 9:603–15
Clavel, M., Soukop, M., Greenstreet, Y. L. (1993). Improved control of emesis and quality of life with ondansetron in breast cancer.Oncology 50:180–5
Haes, J. C., Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer.Annals of Oncology 9:745–50
Soukop, M., McQuade, B., Hunter, E.et al. (1992). Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer.Oncology 49:295–304
Goldberg, J. A., Scott, R. N., Davidson, P. M.et al. (1992). Psychological morbidity in the first year after breast surgery.European Journal of Surgical Oncology 18:327–31
Kiebert, G. M., Hanneke, J., Haes, C. J.et al. (1990). Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer.European Journal of Cancer 26:1038–42
Fulton, C. L. (1997). The physical and psychological symptoms experienced by patients with metastatic breast cancer before death.European Journal of Cancer Care (England) 6:262–6
Hopwood, P., Howell, A., Maguire, P. (1991). Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires.British Journal of Cancer 64:349–52
Ramirez, A. J., Towlson, K. E., Leaning, M. S.et al. (1998). Do patients with advanced breast cancer benefit from chemotherapy?British Journal of Cancer 78:1488–94
Harper-Wynne, C., English, J., Meyer, L.et al. (1999). Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast.British Journal of Cancer 81:316–22
Joensuu, H., Holli, K., Heikkinen, M.et al. (1998). Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.Journal of Clinical Oncology 16:3720–30
Richards, M. A., Hopwood, P., Ramirez, A. J.et al. (1992). Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life.European Journal of Cancer 28A:1023–8
Buzdar, A. U., Jones, S. E., Vogel, C. L.et al. (1997). A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.Cancer 79:730–9
Kramer, J. A., Curran, D., Piccart, M.et al. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist.European Journal of Cancer 36:1488–97
Hopwood, P., Howell, A., Maguire, P. (1991). Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires.British Journal of Cancer 64:353–6
Paci, E. (1992). Assessment of validity and clinical application of an Italian version of the Rotterdam Symptom Checklist.Quality of Life Research 1:129–34
Steginga, S., Occhipinti, S., Wilson, K.et al. (1998). Domains of distress: the experience of breast cancer in Australia.Oncology Nursing Forum 25:1063–70
Ganz, P. A., Schag, C. C., Polinsky, M. L.et al. (1987). Rehabilitation needs and breast cancer: the first month after primary therapy.Breast Cancer Research and Treatment 10:243–53
Ganz, P. A., Rowland, J. H., Desmond, K.et al. (1998). Life after breast cancer: understanding women's health-related quality of life and sexual functioning.Journal of Clinical Oncology 16:501–14
Ganz, P. A., Greendale, G. A., Petersen, L.et al. (2000). Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial.Journal of the National Cancer Institute 92:1054–64
Ganz, P. A., Desmond, K. A., Leedham, B.et al. (2002). Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study.Journal of the National Cancer Institute 94:39–49
Ganz, P. A.Lee, J. J., Sim, M. S.et al. (1992). Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer.Journal of Clinical Epidemiology 45:473–85
Ganz, P. A., Hirji, K., Sim, M. S.et al. (1993). Predicting psychosocial risk in patients with breast cancer.Medical Care 31:419–31
Frost, M. H., Arvizu, R. D., Jayakumar, S.et al. (1999). A multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustment.Oncology Nursing Forum 26:1673–80
Wyatt, G. K., Friedman, L. L. (1998). Physical and psychosocial outcomes of midlife and older women following surgery and adjuvant therapy for breast cancer.Oncology Nursing Forum 25:761–8
Rustoen, T., Moum, T., Wiklund, I.et al. (1999). Quality of life in newly diagnosed cancer patients.Journal of Advanced Nursing 29:490–8
Shimozuma, K., Ganz, P. A., Petersen, L.et al. (1999). Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery.Breast Cancer Research and Treatment 56:45–57
Rustoen, T., Wiklund, I., Hanestad, B. R.et al. (1998). Nursing intervention to increase hope and quality of life in newly diagnosed cancer patients.Cancer Nursing 21:235–45
Ganz, P. A., Rowland, J. H., Meyerowitz, B. E.et al. (1998). Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors.Recent Results Cancer Research 152:396–411
Rowland, J. H., Desmond, K. A., Meyerowitz, B. E.et al. (2000). Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors.Journal of the National Cancer Institute 92:1422–9
Ashing-Giwa, K., Ganz, P. A., Petersen, L. (1999). Quality of life of African-American and white long term breast carcinoma survivors.Cancer 85:418–26
Frost, M. H., Suman, V. J., Rummans, T. A.et al. (2000). Physical, psychological and social well-being of women with breast cancer: the influence of disease phase.Psycho-Oncology 9:221–31
Aaronson, N. K., Ahmedzai, S., Bullinger, M. et al. (1987). The EORTC core quality of life questionnaire: Interim results of an international field study. In Effect of Cancer on Quality of Life, ed. D. Osoba, pp. 185–203. Boston: Yale University Press
Aaronson, N. K., Cull, A., Kaasa, S.et al. (1994). The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology.International Journal of Mental Health 23:75–96
Kaasa, S., Bjordal, K., Aaronson, N.et al. (1995). The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.European Journal of Cancer 31A:2260–3
Osoba, D., Zee, B., Pater, J.et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.Quality of Life Research 3:353–64
Niezgoda, H. E., Pater, J. L. (1993). A validation study of the domains of the core EORTC quality of life questionnaire.Quality of Life Research 2:319–25
McLachlan, S. A., Devins, G. M., Goodwin, P. J. (1999). Factor analysis of the psychosocial items of the EORTC QLQ-C30 in metastatic breast cancer patients participating in a psychosocial intervention study.Quality of Life Research 8:311–17
Chie, W. C., Huang, C. S., Chen, J. H.et al. (1999). Measurement of the quality of life during different clinical phases of breast cancer.Journal of Formosan Medical Association 98:254–60
Taenzer, P. A., Speca, M., Atkinson, M. J.et al. (1997). Computerized quality-of-life screening in an oncology clinic.Cancer Practice 5:168–75
Carlsson, M., Hamrin, E. (1996). Measurement of quality of life in women with breast cancer. Development of a Life Satisfaction Questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30.Quality of Life Research 5:265–74
Mercier, M., Bonneterre, J., Schraub, S.et al. (1998). The development of a French version of a questionnaire on the quality of life in cancerology (Functional Living Index-Cancer: FLIC).Bulletin du Cancer 85:180–6
King, M. T., Dobson, A. J., Harnett, P. R. (1996). A comparison of two quality-of-life questionnaires for cancer clinical trials: the functional living index—cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30).Journal of Clinical Epidemiology 49:21–9
McLachlan, S. A., Devins, G. M., Goodwin, P. J. (1998). Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.European Journal of Cancer 34:510–17
McLachlan, S. A., Pintilie, M., Tannock, I. F. (1999). Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost.Breast Cancer Research and Treatment 54:213–23
Osoba, D., Rodrigues, G., Myles, J.et al. (1998). Interpreting the significance of changes in health-related quality-of-life scores.Journal of Clinical Oncology 16:139–44
Wilson, K. A., Dowling, A. J., Abdolell, M.et al. (2000). Perception of quality of life by patients, partners and treating physicians.Quality of Life Research 9:1041–52
Apolone, G., Filiberti, A., Cifani, S.et al. (1998). Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.Annals of Oncology 9:549–57
Kemmler, G., Holzner, B., Kopp, M.et al. (1999). Comparison of two quality-of-life instruments for cancer patients: the Functional Assessment of Cancer Therapy—General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.Journal of Clinical Oncology 17:2932–40
Montazeri, A., Harirchi, I., Vahdani, M.et al. (2000). The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version.Quality of Life Research 9:177–84
Klee, M., Groenvold, M., Machin, D. (1997). Quality of life of Danish women: population-based norms of the EORTC QLQ-C30.Quality of Life Research 6:27–34
Macquart-Moulin, G., Viens, P., Palangie, T.et al. (2000). High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?Journal of Clinical Oncology 18:754–64
King, M. T., Kenny, P., Shiell, A.et al. (2000). Quality of life three months and one year after first treatment for early stage breast cancer: influence of treatment and patient characteristics.Quality of Life Research 9:789–800
Grunfeld, E., Mant, D., Yudkin, P.et al. (1996). Routine follow up of breast cancer in primary care: randomised trial.British Medical Journal 313:665–9
Dam, F. S., Schagen, S. B., Muller, M. J.et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.Journal of the National Cancer Institute 90:210–18
Cohen, L., Hack, T. F., Moor, C.et al. (2000). The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment.Annals of Surgical Oncology 7:427–34
Kornblith, A.Herndon, B., , J. E., Zuckerman, E.et al. (2001). Social support as a buffer to the psychological impact of stressful life events in women with breast cancer.Cancer 91:443–54
Kramer, J. A., Curran, D., Piccart, M.et al. (2000). Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.European Journal of Cancer 36:1498–506
Pater, J. L., Zee, B., Palmer, M.et al. (1997). Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30.Supportive Care in Cancer 5:410–13
Curran, D., Aaronson, N., Standaert, B.et al. (2000). Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study.European Journal of Cancer 36:834–44
Geels, P., Eisenhauer, E., Bezjak, A.et al. (2000). Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer.Journal of Clinical Oncology 18:2395–405
Kristensen, B., Ejlertsen, B., Groenvold, M.et al. (1999). Oral clodronate in breast cancer patients with bone metastases: a randomized study.Journal of Internal Medicine 246:67–74
Osoba, D., Burchmore, M. (1999). Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin).Seminars in Oncology 26:84–8
Kaufmann, M., Bajetta, E., Dirix, L. Y.et al. (2000). Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.Journal of Clinical Oncology 18:1399–411
Nabholtz, J. M., Senn, H. J., Bezwoda, W. R.et al. and 304 Study Group (1999). Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.Journal of Clinical Oncology 17:1413–24
Norris, B., Pritchard, K. I., James, K.et al. (2000). Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8.Journal of Clinical Oncology 18:2385–94
Hack, T. F., Cohen, L., Katz, J.et al. (1999). Physical and psychological morbidity after axillary lymph node dissection for breast cancer.Journal of Clinical Oncology 17:143–9
Kissane, D. W., Clarke, D. M., Ikin, J.et al. (1998). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey [see comments].Medical Journal of Australia 169:192–6
Holzner, B., Kemmler, G., Kopp, M.et al. (2001). Quality of life in breast cancer patients — not enough attention for long-term survivors?Psychosomatics 42:117–23
Hakamies-Blomqvist, L., Luoma, M., Sjostrom, J.et al. (2000). Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.European Journal of Cancer 36:1411–17
Joly, F., Espie, M., Marty, M., Heron, J. F.et al. (2000). Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.British Journal of Cancer 83:577–82
Stanton, A. L., Danoff-Burg, S., Cameron, C. L.et al. (2000). Emotionally expressive coping predicts psychological and physical adjustment to breast cancer.Journal of Consulting and Clinical Psychology 68:875–82
Dow, K. H., Ferrell, B. R., Leigh, S.et al. (1996). An evaluation of the quality of life among long-term survivors of breast cancer.Breast Cancer Research and Treatment 39:261–73
Wenzel, L. B., Fairclough, D. L., Brady, M. J.et al. (1999). Age-related differences in the quality of life of breast carcinoma patients after treatment.Cancer 86:1768–74
Ritz, L. J., Nissen, M. J., Swenson, K. K.et al. (2000). Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer.Oncology Nursing Forum 27:923–32
Nissen, M. J., Swenson, K. K., Ritz, L. J.et al. (2001). Quality of life after breast carcinoma surgery: a comparison of three surgical procedures.Cancer 91:1238–46
Richardson, M. A., Post-White, J., Grimm, E. A.et al. (1997). Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment.Alternative Therapies in Health and Medicine 3:62–70
Ware, J. E., Sherbourne, C. D.Jr. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.Medical Care 30:473–83
McHorney, C. A., Ware, J. E., Raczek, A. E.Jr. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.Medical Care 31:247–63
McHorney, C. A., Ware, J. E. Jr., Lu, J. F.et al. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.Medical Care 32:40–66
Ganz, P. A., Greendale, G. A., Kahn, B.et al. (1999). Are older breast carcinoma survivors willing to take hormone replacement therapy?Cancer 86:814–20
Stein, K. D., Jacobsen, P. B., Hann, D. M.et al. (2000). Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer.Journal of Pain and Symptom Management 19:436–45
Burstein, H. J., Gelber, S., Guadagnoli, E.et al. (1999). Use of alternative medicine by women with early-stage breast cancer.New England Journal of Medicine 340:1733–9
Bloom, J. R., Stewart, S. L., Johnston, M., Banks, P. (1998). Intrusiveness of illness and quality of life in young women with breast cancer.Psycho-Oncology 7:89–100
Velanovich, V., Szymanski, W. (1999). Quality of life of breast cancer patients with lymphedema.American Journal of Surgery 177:184
Maunsell, E., Brisson, J., Deschenes, L.et al. (1996). Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life.Journal of Clinical Oncology 14:2747–55
Bower, J. E., Ganz, P. A., Desmond, K. A.et al. (2000). Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.Journal of Clinical Oncology 18:743–53
Broeckel, J. A., Jacobsen, P. B., Balducci, L.et al. (2000). Quality of life after adjuvant chemotherapy for breast cancer.Breast Cancer Research and Treatment 62:141–50
Andrykowski, M. A., Curran, S. L., Studts, J. L.et al. (1996). Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: a controlled comparison.Journal of Clinical Epidemiology 49:827–34
Jacobsen, P. B., Widows, M. R., Hann, D. M.et al. (1998). Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer.Psychosomatic Medicine 60:366–71
Hann, D. M., Jacobsen, P. B., Martin, S. C.et al. (1997). Quality of life following bone marrow transplantation for breast cancer: a comparative study.Bone Marrow Transplantation 19:257–64
Wapnir, I. L., Cody, R. P., Greco, R. S. (1999). Subtle differences in quality of life after breast cancer surgery.Annals of Surgical Oncology 6:359–66
Stearns, V., Isaacs, C., Rowland, J.et al. (2000). A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.Annals of Oncology 11:17–22
Hann, D. M., Jacobsen, P. B., Azzarello, L. M.et al. (1998). Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.Quality of Life Research 7:301–10
Dorval, M., Maunsell, E., Deschenes, L.et al. (1998). Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls.Journal of Clinical Oncology 16:487–94
McCaul, K. D., Sandgren, A. K., King, B.et al. (1999). Coping and adjustment to breast cancer.Psycho-Oncology 8:230–6
Carpenter, J. S., Andrykowski, M. A., Cordova, M.et al. (1998). Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life.Cancer 82:1682–91
Cordova, M. J., Andrykowski, M. A., Kenady, D. E.et al. (1995). Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer.Journal of Consulting and Clinical Psychology 63:981–6
Zigmond, A. S., Snaith, R. P. (1983). The hospital anxiety and depression scale.Acta Psychiatrica Scandinavica 67:361–70
Groenvold, M., Fayers, P. M., Sprangers, M. A.et al. (1999). Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison?Journal of Clinical Epidemiology 52:523–30
Watson, M., Greer, S., Rowden, L.et al. (1991). Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients.Psychological Medicine 21:51–7
Razavi, D., Delvaux, N., Farvacques, C.et al. (1993). Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam.Journal of Clinical Oncology 11:1384–90
Wallace, L. M., Priestman, S. G., Dunn, J. A.et al. (1993). The quality of life of early breast cancer patients treated by two different radiotherapy regimens.Clinical Oncology (Royal College of Radiologists) 5:228–33
Spiegel, D., Morrow, G. R., Classen, C.et al. (1999). Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study.Psycho-Oncology 8:482–93
Fukui, S., Kugaya, A., Okamura, H.et al. (2000). A psychosocial group intervention for Japanese women with primary breast carcinoma.Cancer 89:1026–36
Watson, M., Haviland, J. S., Greer, S.et al. (1999). Influence of psychological response on survival in breast cancer: a population-based cohort study.Lancet 354:1331–6
Millar, K., Jelicic, M., Bonke, B.et al. (1995). Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer.British Journal of Anesthesia 74:180–3
Brezden, C. B., Phillips, K. A., Abdolell, M.et al. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy.Journal of Clinical Oncology 18:2695–701
Cimprich, B. (1999). Pretreatment symptom distress in women newly diagnosed with breast cancer.Cancer Nursing 22:185–94
Graydon, J. E. (1994). Women with breast cancer: their quality of life following a course of radiation therapy.Journal of Advanced Nursing 19:617–22
Miaskowski, C., Dibble, S. L. (1995). The problem of pain in outpatients with breast cancer.Oncology Nursing Forum 22:791–7
Romsaas, E. P., Malec, J. F., Javenkoski, B. R.et al. (1986). Psychological distress among women with breast problems.Cancer 57:890–5
Wolberg, W. H., Tanner, M. A., Romsaas, E. P.et al. (1987). Factors influencing options in primary breast cancer treatment.Journal of Clinical Oncology 5:68–74
Levy, S. M., Herberman, R. B., Lee, J. K.et al. (1989). Breast conservation versus mastectomy: distress sequelae as a function of choice.Journal of Clinical Oncology 7:367–75
Schwartz, A. L. (1999). Fatigue mediates the effects of exercise on quality of life.Quality of Life Research 8:529–38
Swain, S. M., Rowland, J., Weinfurt, K.et al. (1996). Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life.Journal of Clinical Oncology 14:1565–72
Bridge, L. R., Benson, P., Pietroni, P. C.et al. (1988). Relaxation and imagery in the treatment of breast cancer.British Medical Journal 297:1169–72
Pozo, C., Carver, C. S., Noriega, V.et al. (1992). Effects of mastectomy versus lumpectomy on emotional adjustment to breast cancer: a prospective study of the first year postsurgery.Journal of Clinical Oncology 10:1292–8
Wolberg, W. H., Romsaas, E. P., Tanner, M. A.et al. (1989). Psychosexual adaptation to breast cancer surgery.Cancer 63:1645–55
Bultz, B. D., Speca, M., Brasher, P. M.et al. (2000). A randomized controlled trial of a brief psychoeducational support group for partners of early stage breast cancer patients.Psycho-Oncology 9:303–13
McQuellon, R. P., Craven, B., Russell, G. B.et al. (1996). Quality of life in breast cancer patients before and after autologous bone marrow transplantation.Bone Marrow Transplantation 18:579–84
Broeckel, J. A., Jacobsen, P. B., Horton, J.et al. (1998). Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.Journal of Clinical Oncology 16:1689–96
Levy, S. M., Haynes, L. T., Herberman, R. B.et al. (1992). Mastectomy versus breast conservation surgery: mental health effects at long-term follow-up.Health Psychology 11:349–54
Interdisciplinary Group for Cancer Care Evaluation (GIVIO). Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. (1994). Journal of the American Medical Association 271:1587–92
Classen, C., Koopman, C., Angell, K.et al. (1996). Coping styles associated with psychological adjustment to advanced breast cancer.Health Psychology 15:434–7
Koopman, C., Hermanson, K., Diamond, S.et al. (1998). Social support, life stress, pain and emotional adjustment to advanced breast cancer.Psycho-Oncology 7:101–11
Ahles, T. A., Tope, D. M., Furstenberg, C.et al. (1996). Psychologic and neuropsychologic impact of autologous bone marrow transplantation.Journal of Clinical Oncology 14:1457–62
Classen, C., Butler, L. D., Koopman, C.et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial.Archives of General Psychiatry 58:494–501
Edelman, S., Bell, D. R., Kidman, A. D. (1999). A group cognitive behaviour therapy programme with metastatic breast cancer patients.Psycho-Oncology 8:295–305
Tannock, I. F., Boyd, N. F., DeBoer, G.et al. (1988). A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.Journal of Clinical Oncology 6:1377–87
Butow, P., Coates, A., Dunn, S.et al. (1991). On the receiving end. IV: Validation of quality of life indicators.Annals of Oncology 2:597–603
Hurny, C., Bernhard, J., Gelber, R. D.et al. (1992). Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.European Journal of Cancer 28:118–24
Hurny, C., Bernhard, J., Bacchi, M.et al. (1993). The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).Supportive Care in Cancer 1:200–8
Whelan, T. J., Levine, M., Julian, J.et al. (2000). The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group.Cancer 88:2260–6
Levine, M. N., Bramwell, V. H., Pritchard, K. I.et al. (1998). Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.Journal of Clinical Oncology 16:2651–8
Fetting, J. H., Gray, R., Fairclough, D. L.et al. (1998). Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.Journal of Clinical Oncology 16:2382–91
Bernhard, J., Hurny, C., Coates, A. S.et al. (1997). Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group [published erratum appears in Ann Oncol (1998) 9(2):231].Annals of Oncology 8:825–35
Coates, A. S., Hurny, C., Peterson, H. F.et al. (2000). Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.Journal of Clinical Oncology 18:3768–74
Bull, A. A., Meyerowitz, B. E., Hart, S.et al. (1999). Quality of life in women with recurrent breast cancer.Breast Cancer Research and Treatment 54:47–57
Litwin, M. S., Hays, R. D., Fink, A.et al. (1995). Quality-of-life outcomes in men treated for localized prostate cancer.Journal of the American Medical Association 273:129–35
Guyatt, G. H., Kirshner, B., Jaeschke, R. (1992). Measuring health status: what are the necessary measurement properties?Journal of Clinical Epidemiology 45:1341–5
Goodwin, P. J., Black, J. T., Bordeleau, L. J.et al. (2003). Health-related quality of life measurement in randomized clinical trials in breast cancer — taking stock.Journal of the National Cancer Institute 95:263–81
Poulsen, B., Graversen, H. P., Beckmann, J.et al. (1997). A comparative study of post-operative psychosocial function in women with primary operable breast cancer randomized to breast conservation therapy or mastectomy.European Journal of Surgical Oncology 23:327–34
Curran, D., Dongen, J. P., Aaronson, N. K.et al. (1998). Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG).European Journal of Cancer 34:307–14
Haes, J. C., Oostrom, M. A., Welvaart, K. (1986). The effect of radical and conserving surgery on the quality of life of early breast cancer patients.European Journal of Surgical Oncology 12:337–42
Kemeny, M. M., Wellisch, D. K., Schain, W. S. (1988). Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer.Cancer 62:1231–7
Bates, T., Riley, D. L., Houghton, J.et al. (1991). Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party.British Journal of Surgery 78:591–4
Hurny, C., Bernhard, J., Coates, A. S.et al. (1996). Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group [published erratum appears in Lancet (1997) 350(9073):298].Lancet 347:1279–84
Nystedt, M., Berglund, G., Bolund, C.et al. (2000). Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer — self-rated physiological effects and symptoms.Acta Oncologica 39:959–68
Fairclough, D. L., Fetting, J. H., Cella, D.et al. (1999). Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG).Quality of Life Research 8:723–31
Fraser, S. C., Dobbs, H. J., Ebbs, S. R.et al. (1993). Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.British Journal of Cancer 67:402–6
Kloke, O., Klaassen, U., Oberhoff, C.et al. (1999). Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group.Breast Cancer Research and Treatment 55:51–9
Buzdar, A., Douma, J., Davidson, N.et al. (2001). Phase III, multicenter, double-blind, randomized study of Letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.Journal of Clinical Oncology 19:3357–66
Goss, P. E., Winer, E. P., Tannock, I. F.et al. (1999). Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group.Journal of Clinical Oncology 17:52–63
Bertsch, L. A., Donaldson, G. (1995). Quality of life analyses from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer.Seminars in Oncology 22:45–53
Stewart, D. J., Evans, W. K., Shepherd, F. A.et al. (1997). Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.Journal of Clinical Oncology 15:1897–905
Riccardi, A., Tinelli, C., Brugnatelli, S.et al. (2000). Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer.International Journal of Oncology 16:769–76
Holten-Verzantvoort, A. T., Zwinderman, A. H., Aaronson, N. K.et al. (1991). The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer.European Journal of Cancer 27:544–9
Hultborn, R., Gundersen, S., Ryden, S.et al. (1996). Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study.Acta Oncologica 35 (Suppl. 5):73–4
Pandya, K. J., Raubertas, R. F., Flynn, P. J.et al. (2000). Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.Annals of Internal Medicine 132:788–93
Dixon, A. K., Wheeler, T. K., Lomas, D. J.et al. (1993). Computed tomography or magnetic resonance imaging for axillary symptoms following treatment of breast carcinoma? A randomized trial.Clinical Radiology 48:371–6
Marchioro, G., Azzarello, G., Checchin, F.et al. (1996). The impact of a psychological intervention on quality of life in non-metastatic breast cancer.European Journal of Cancer 32A:1612–15
Walker, L. G., Walker, M. B., Ogston, K.et al. (1999). Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy.British Journal of Cancer 80:262–8
Sandgren, A. K., McCaul, K. D., King, B.et al. (2000). Telephone therapy for patients with breast cancer.Oncology Nursing Forum 27:683–8
Goodwin, P. J., Leszcz, M., Ennis, M.et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer.New England Journal of Medicine 345:1719–26
Spiegel, D., Bloom, J. R., Kraemer, H. C.et al. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer.Lancet 2:888–91
Fogarty, L. A., Curbow, B. A., Wingard, J. R.et al. (1999). Can 40 seconds of compassion reduce patient anxiety?Journal of Clinical Oncology 17:371–9
Christensen, D. N. (1983). Postmastectomy couple counseling: an outcome study of a structured treatment protocol.Journal of Sex and Marital Therapy 9:266–75
Wengström, Y., Häggmark, C., Strander, H.et al. (1999). Effects of a nursing intervention on subjective distress, side effects and quality of life of breast cancer patients receiving curative radiation.Acta Oncologica 38:763–70
Helgeson, V. S., Cohen, S. (2001). Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer.Health Psychology 20:387–92
Arathuzik, D. (1994). Effects of cognitive-behavioral strategies on pain in cancer patients.Cancer Nursing 17:207–14
Bordeleau, L., Szalai, J. P., Goodwin, P. J.et al. (2002). Quality of life (QOL) and psychosocial support in women with metastatic breast cancer (MBC): results of a multicenter randomized trial.Proceedings of the American Society of Clinical Oncology 21: A1424
Cunningham, A. J., Edmonds, C. V., Jenkins, G. P.et al. (1998). A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer.Psycho-Oncology 7:508–17
Coates, A., Gebski, V., Signorini, D.et al. (1992). Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.Journal of Clinical Oncology 10:1833–8
Simes, R. J., Coates, A. S. (2001). Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?Journal of the National Cancer Institute Monographs 30:146–52
Moinpour, C. M. (1996). Costs of quality-of-life research in Southwest Oncology Group trials.Journal of the National Cancer Institute Monographs 20:11–16
Bernhard, J., Cella, D. F., Coates, A. S.et al. (1998). Missing quality of life data in cancer clinical trials: serious problems and challenges.Statistics in Medicine 17:517–32
Ganz, P. A., Day, R., Ware, J. E. Jr.et al. (1995). Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial.Journal of the National Cancer Institute 87:1372–82
Day, R., Ganz, P. A., Costantino, J. P.et al. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study.Journal of Clinical Oncology 17:2659–69
Osoba, this volume, Chapter 19
Lippman, M. E., Hayes, D. F. (2001). Adjuvant therapy for all patients with breast cancer?Journal of the National Cancer Institute 93:80–2
Kiebert, G. M., Haes, J. C., Velde, C. J. (1991). The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review.Journal of Clinical Oncology 9:1059–70
Fallowfield, L. (1997). Offering choice of surgical treatment to women with breast cancer.Patient Education and Counseling 30:209–14
Moyer, A. (1997). Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review [published erratum appears in Health Psychology 1997 16(5):442].Health Psychology 16:284–98
Ganz, P. A., Desmond, K. A., Belin, T. R.et al. (1999). Predictors of sexual health in women after a breast cancer diagnosis.Journal of Clinical Oncology 17:2371–80